Publication at Third Faculty of Medicine |
2021
Abstract
Despite continuous research in the field of schizophrenia, there are still limiting factors in treatment of this illness. Remission is often of poor-quality because of adverse effects of medication, negative symptoms and cognitive deterioration.
Recently new antipsychotic promising advance in limitations mentioned above were introduced. One of those is cariprazine, partial agonist of dopamine receptors.
Several articles regarding its advantages have been already published in Czech literature. We present this following case study as an example of practical use of this medication.